Avidity of IgG to SARS-CoV-2 RBD as a Prognostic Factor for the Severity of COVID-19 Reinfection

Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection

(2021) Jennifer M. Dan et al.   SCIENCE

The potential significance of high avidity IgG for protective immunity towards SARS-CoV-2

(2021) Georg Bauer   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Avidity assay to test functionality of anti-SARS-Cov-2 antibodies

(2021) Emanuelle Baldo Gaspar et al.   VACCINE

The protective effect of previous COVID-19 infection in a high-prevalence hospital setting

(2021) Favian Narrainen et al.   CLINICAL MEDICINE

Rate and severity of suspected SARS-Cov-2 reinfection in a cohort of PCR-positive COVID-19 patients

(2021) Jeff Slezak et al.   CLINICAL MICROBIOLOGY AND INFECTION

Seroprevalence of SARS-CoV-2 antibodies and reduced risk of reinfection through six months: a Danish observational cohort study of 44,000 healthcare workers

(2021) Kasper Iversen et al.   CLINICAL MICROBIOLOGY AND INFECTION

Temporal maturation of neutralizing antibodies in COVID-19 convalescent individuals improves potency and breadth to circulating SARS-CoV-2 variants

(2021) Saya Moriyama et al.   IMMUNITY

Serologic Status and SARS-CoV-2 Infection over 6 Months of Follow Up in Healthcare Workers in Chicago: A Cohort Study

(2021) John T. Wilkins et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Incomplete IgG avidity maturation after seasonal coronavirus infections

(2021) Friedhelm Struck et al.   JOURNAL OF MEDICAL VIROLOGY

Vaccination versus infection with SARS‐CoV‐2: Establishment of a high avidity IgG response versus incomplete avidity maturation

(2021) Friedhelm Struck et al.   JOURNAL OF MEDICAL VIROLOGY

Assessment of avidity related to IgG subclasses in SARS-CoV-2 Brazilian infected patients

(2021) Andrew D. Moura et al.   Scientific Reports

Neutralizing Activity of Sera from Sputnik V-Vaccinated People against Variants of Concern (VOC: B.1.1.7, B.1.351, P.1, B.1.617.2, B.1.617.3) and Moscow Endemic SARS-CoV-2 Variants

(2021) Vladimir A. Gushchin et al.   Vaccines

Immune response variables and viral mutations impact on COVID-19 reinfection and relapse

(2021) Sarvin Sanaie et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein

(2020) Alexandra C. Walls et al.   CELL

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

(2020) Markus Hoffmann et al.   CELL

Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies

(2020) Christopher O. Barnes et al.   CELL

The variability of the serological response to SARS‐corona virus‐2: Potential resolution of ambiguity through determination of avidity (functional affinity)

(2020) Georg Bauer   JOURNAL OF MEDICAL VIROLOGY

Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology

(2020) Luca Piccoli et al.   CELL

Kinetics of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Avidity Maturation and Association with Disease Severity

(2020) Yiqi Ruben Luo et al.   CLINICAL INFECTIOUS DISEASES

Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population

(2020) Sabra L. Klein et al.   JOURNAL OF CLINICAL INVESTIGATION

SARS-CoV-2 Antibody Avidity Responses in COVID-19 Patients and Convalescent Plasma Donors

(2020) Sarah E Benner et al.   JOURNAL OF INFECTIOUS DISEASES

SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies

(2020) Christopher O. Barnes et al.   NATURE

Seasonal coronavirus protective immunity is short-lasting

(2020) Arthur W. D. Edridge et al.   NATURE MEDICINE

Blocking of the High-Affinity Interaction-Synapse Between SARS-CoV-2 Spike and Human ACE2 Proteins Likely Requires Multiple High-Affinity Antibodies: An Immune Perspective

(2020) Indu Khatri et al.   Frontiers in Immunology

Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers

(2020) Sheila F. Lumley et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Application and Interpretation of IgG Avidity and IgA ELISA Tests to Characterize Zika Virus Infections

(2019) Fátima Amaro et al.   Viruses-Basel

Diagnosis of Zika virus infection on a nanotechnology platform

(2017) Bo Zhang et al.   NATURE MEDICINE